United States · FDA National Drug Code directory
LOMAIRA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10702-001_0ce01306-ef7f-563f-e063-6394a90a52b7
- Product NDC
- 10702-001
- Form
- TABLET
- Composition / generic term
- Phentermine Hydrochloride
- Labeler
- KVK-TECH, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160912
- Source listing expiry
- 20261231
Source-listed ingredients
- PHENTERMINE HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (10702-001-03) · 10702-001-03
- 60 TABLET in 1 BOTTLE (10702-001-06) · 10702-001-06
- 90 TABLET in 1 BOTTLE (10702-001-09) · 10702-001-09
- 1000 TABLET in 1 BOTTLE (10702-001-10) · 10702-001-10
- 250 TABLET in 1 BOTTLE (10702-001-25) · 10702-001-25
- 500 TABLET in 1 BOTTLE (10702-001-50) · 10702-001-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →